Publication:
Mid-esophageal ulceration and candidiasis-associated distal esophagitis as two distinct clinical patterns of tetracycline or doxycycline-induced esophageal injury

dc.contributor.authorsGencosmanoglu, R; Kurtkaya-Yapicier, O; Tiftikci, A; Avsar, E; Tozun, N; Sen Oran, E
dc.date.accessioned2022-03-12T17:16:26Z
dc.date.accessioned2026-01-11T11:32:39Z
dc.date.available2022-03-12T17:16:26Z
dc.date.issued2004
dc.description.abstractBackground: Tetracyclines may cause esophageal injury Goals: The aims of this study are to describe 2 distinct clinical patterns of esophageal injury induced by tetracycline or its derivate doxycycline and to compare these patterns with respect to demographic, endoscopic, and clinical characteristics of the patients. Study: Forty-eight patients with the diagnosis of doxycycline- or tetracycline-induced esophageal injury by endoscopy were analyzed retrospectively. The patients were considered in 2 groups according to the type and the location of esophageal lesions (Group A: mid-esophageal ulceration, n = 18; Group B: distal esophagitis, n 30). 9 Results: Patients in Group A were significantly younger than in Group B (P = 0.0014). In Group A, 15 patients (83%) had single ulceration, 2 (11%) double, and 1 (6%) circumferential at the mid-esophagus. In Group B, all patients had multiple micro-ulcerations in the distal esophagus. Development of mid-esophageal ulceration was induced predominantly by doxycycline, whereas distal esophagitis was induced by tetracycline. The description of drug ingestion with little or no water by patients in Group A was significantly more frequent than in Group B (94% vs. 10%, P < 0.001). Associated medical and benign gastric diseases and esophageal candidiasis were significantly more frequent in Group B (P = 0.006, P < 0.001, P < 0.001, respectively). Prompt response to medical therapy was observed in both groups with no significant difference (P = 0.093). Conclusions: The type of tetracyclines used by patients may give some clues to physicians on the pattern of esophageal injury because mid-esophageal ulceration seems to be more frequently associated with doxycycline and distal esophagitis with or without candidiasis with tetracycline.
dc.identifier.doi10.1097/01.mcg.0000129058.69524.90
dc.identifier.issn0192-0790
dc.identifier.pubmed15220682
dc.identifier.urihttps://hdl.handle.net/11424/227574
dc.identifier.wosWOS:000222187500003
dc.language.isoeng
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.relation.ispartofJOURNAL OF CLINICAL GASTROENTEROLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectdrug-induced esophageal injury
dc.subjectesophageal ulceration
dc.subjectdistal esophagitis
dc.subjecttetracycline
dc.subjectcandidiasis
dc.subjectDRUG-INDUCED ESOPHAGITIS
dc.subjectTHERAPY
dc.subjectTABLETS
dc.subjectTRANSIT
dc.subjectULCERS
dc.titleMid-esophageal ulceration and candidiasis-associated distal esophagitis as two distinct clinical patterns of tetracycline or doxycycline-induced esophageal injury
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage489
oaire.citation.issue6
oaire.citation.startPage484
oaire.citation.titleJOURNAL OF CLINICAL GASTROENTEROLOGY
oaire.citation.volume38

Files